Tobacco use in people with severe mental illness: Findings from a multi-country survey of mental health institutions in South Asia.
Journal Information
Full Title: Tob Induc Dis
Abbreviation: Tob Induc Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Substance Abuse
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"CONFLICTS OF INTEREST The authors have each completed and submitted an ICMJE form for disclosure of potential conflicts of interest. The authors declare that they have no competing interests, financial or otherwise, related to the current work. S. Rajan and K.P. Muliyala report that since the initial planning of the work, this research was funded by the National Institute for Health Research (NIHR) (grant number GHRG 17/63/130; awarded to NS), using UK aid from the UK Government to support global health research and that the payments were made to the Institution (NIMHANS) through the University of York. D. Shiers reports that since the initial planning of the work, received personal fees from Wiley Blackwell, and in the past 36 months received consulting fees from the IRAS project (ID: 301232), payments/honoraria for presentations at educational events, travel reimbursement from University College London, payment as incurred expenses by Greater Manchester Mental Health NHS Foundation Trust, paid participation on a Data Safety Monitoring Board, and costs for attendance at other meetings (NIHR Global Health) at the University of York. K. Siddiqi reports that since the initial planning of the work this research was funded from the National Institute for Health Research (17/63/76/ Global Health Research Groups ASTRA) which funded the author's contribution to this manuscript."
"FUNDING IMPACT and ASTRA are funded by the NIHR, using UK aid from the UK government to support global health research (programme reference 17/63/130/ and 17/63/76/ Global Health Research Groups)."
"This study utilized data collected as part of a cross-sectional survey of health, health-risk behaviors, and healthcare use in people with SMI in three South Asian countries: the IMPACT study [ISRCTN registry: 88485933],. The survey included people aged ≥18 years with a clinician-diagnosed SMI. The diagnoses were confirmed using the international neuropsychiatric interview - MINI version 6.0 and included schizophrenia, schizoaffective disorder, severe depression with psychotic symptoms, and bipolar affective disorder. The participants attended three national institutes of mental health in Bangladesh, India, and Pakistan, between July 2019 and March 2022. STUDY REGISTRATION: ISRCTN88485933; https://doi.org/10.1186/ISRCTN88485933 39"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025